Q4 2018 Holdings
Filed 2019-02-12 | 133 holdings | $3.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CoreCivic, Inc.(CXW) | Common | 21871N101 | $1.3M | 75,000 | 34.2% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | Common | 14888U101 | $1.2M | 613,447 | 30.2% |
| Abbvie Inc.(ABBV) | Common | 00287Y109 | $461.0K | 5,000 | 11.8% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $365.0K | 40,369 | 9.3% |
| Columbia Financial Inc.(CLBK) | Common | 197641103 | $357.0K | 23,363 | 9.1% |
| Ligand Pharmaceuticals Incorporated(LGND) | Common | 53220K504 | $46.7K | 344,041 | 1.2% |
| Pfizer Inc.(PFE) | Common | 717081103 | $15.9K | 363,778 | 0.4% |
| Upland Software, Inc.(UPLD) | Common | 91544A109 | $11.4K | 420,000 | 0.3% |
| Mplx LP(MPLX) | Common | 55336V100 | $9.4K | 309,558 | 0.2% |
| Capitol Federal Financial, Inc.(CFFN) | Common | 14057J101 | $8.6K | 671,050 | 0.2% |
| Fortress Trans & Infrastructure Inv. LLC | Common | 34960P101 | $8.3K | 576,064 | 0.2% |
| Apollo Global Management LLC | Common | 037612306 | $7.9K | 322,708 | 0.2% |
| Oracle Corporation(ORCL) | Common | 68389X105 | $6.8K | 150,000 | 0.2% |
| LKQ Corporation(LKQ) | Common | 501889208 | $6.5K | 275,000 | 0.2% |
| Macquarie Infrastructure Corporation | Common | 55608B105 | $6.4K | 175,900 | 0.2% |
| The Michaels Companies, Inc. | Common | 59408Q106 | $5.8K | 430,000 | 0.1% |
| Iridium Communications, Inc.(IRDM) | Common | 46269C102 | $5.2K | 281,600 | 0.1% |
| American Outdoor Brands Corporation(AOBCEUR) | Common | 02874P103 | $4.2K | 330,000 | 0.1% |
| Lowe's Companies Inc.(LOW) | Common | 548661107 | $4.2K | 45,000 | 0.1% |
| The Star Group, Inc. | Common | 85570W100 | $4.0K | 241,920 | 0.1% |
| Apple Inc.(AAPL) | Common | 037833100 | $4.0K | 25,050 | 0.1% |
| Calumet Specialty Products Partners, LP | Common | 131476103 | $3.4K | 1,534,031 | 0.1% |
| Delta Air Lines, Inc.(DAL) | Common | 247361702 | $2.9K | 57,500 | 0.1% |
| The Howard Hughes Corporation(HHC*) | Common | 44267D107 | $2.5K | 25,900 | 0.1% |
| JP Morgan & Chase(JPM) | Common | 46625H100 | $2.3K | 23,050 | 0.1% |
| Intec Pharma Ltd. | Common | M53644106 | $2.1K | 283,473 | 0.1% |
| DowDupont Inc. | Common | 26078J100 | $2.0K | 37,644 | 0.1% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | Common | 09060J106 | $1.9K | 500,300 | 0.0% |
| Viking Therapeutics, Inc.(VKTX) | Common | 92686J106 | $1.8K | 238,102 | 0.0% |
| Noble Energy, Inc.(NBL2EUR) | Common | 655044105 | $1.8K | 96,000 | 0.0% |
| Community Healthcare Trust Incorporated(CHCT) | Common | 20369C106 | $1.7K | 60,000 | 0.0% |
| Arena Pharmaceuticals, Inc.(ARNAEUR) | Common | 040047607 | $1.6K | 39,828 | 0.0% |
| Stemline Therapeutics, Inc. | Common | 85858C107 | $1.5K | 155,795 | 0.0% |
| Horizon Pharma Public Limited Company | Common | G4617B105 | $1.4K | 73,640 | 0.0% |
| AllianceBernstein Holdings LP Unit Ltd.(AB) | Common | 01881G106 | $1.4K | 50,500 | 0.0% |
| Eiger BioPharmaceuticals, Inc.(CLDNEUR) | Common | 28249U105 | $1.3K | 131,333 | 0.0% |
| Radius Health Inc. | Common | 750469207 | $1.3K | 77,269 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | Common | 00900T107 | $1.3K | 52,857 | 0.0% |
| JBS S.A. | Common | 466110103 | $1.1K | 190,400 | 0.0% |
| Xenon Pharmaceuticals Inc.(XENE) | Common | 98420N105 | $1.1K | 173,390 | 0.0% |
| Verizon Communications Inc.(VZ) | Common | 92343V104 | $1.0K | 18,311 | 0.0% |
| Quotient Limited | Common | G73268107 | $1.0K | 167,000 | 0.0% |
| Concert Pharmaceuticals, Inc.(CNCEEUR) | Common | 206022105 | $1.0K | 80,300 | 0.0% |
| Zogenix, Inc. | Common | 98978L204 | $949 | 26,039 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $940 | 7,280 | 0.0% |
| Global Medical REIT, Inc. Ser A Cum Pfd. | Common | 37957W203 | $857 | 35,000 | 0.0% |
| Ryman Hospitality Ppty Inc.(RHP) | Common | 78377T107 | $827 | 12,400 | 0.0% |
| Canadian Natural Resources Inc.(CNQ) | Common | 136385101 | $781 | 32,350 | 0.0% |
| Acceleron Pharma, Inc.(XLRN) | Common | 00434H108 | $758 | 17,400 | 0.0% |
| Foamix Pharmaceuticals Ltd. | Common | M46135105 | $740 | 206,200 | 0.0% |